(Press-News.org) The New England Banksia is largely restricted to the eastern edge of the New England Tableland, and is common in places along Waterfall Way. Ms Stimpson's research has raised this flowering plant, until now classified as a variety of the Hairpin Banksia (B. spinulosa), to the taxonomic level of a distinct species. The study was published in the open access journal PhytoKeys.
"I love the Proteaceae – the family of flowering plants that includes the Banksia and Grevillea genera in Australia and Protea in South Africa," Ms Stimpson said. "Surprisingly, molecular evidence in recent years has shown the family's closest relatives are the Sacred Lotus and the plane trees. Species of Banksia survive in poor soil and still manage to produce marvellous flowers."
Margaret Stimpson wrote the paper in collaboration with Ian Telford, the Curator of the N.C.W. Beadle Herbarium at the University of New England, Professor Jeremy Bruhl, the Director of the herbarium, and Dr Peter Weston, Senior Principal Research Scientist at the National Herbarium of NSW, an international specialist in Proteaceae systematics.
Margaret's first project as an undergraduate student of botany at UNE was on the Proteaceae, and she's been collecting specimens ever since. Now working towards enrolling in a doctoral degree program, she said: "There are still species of Banksia out there that merit description, and I hope to test these in a PhD project."
Margaret established the species rank of the New England Banksia by detailed studies of its leaves, flowers, stem and fruit, and considerations of its ecology and distribution. She explained that it has two growth forms, the more common being a multi-stemmed small shrub with many flowers but few seeds. This form occurs where there has been regular burning, and the seeds need exposure to fire to open. The less common form, found where burning has not occurred, is a single-stemmed tree with many flowers and many seeds that open spontaneously without exposure to fire.
INFORMATION:
Original source:
Stimpson ML, Weston PH, Telford IRH, Bruhl JJ (2012) First instalment in resolution of the Banksia spinulosa complex (Proteaceae): B. neoanglica, a new species supported by phenetic analysis, ecology and geography. PhytoKeys 14: 57-80. doi: 10.3897/phytokeys.14.3415
Posted by Pensoft Publishers.
Botany student proves 'New England Banksia' a distinct species
2012-08-28
ELSE PRESS RELEASES FROM THIS DATE:
Women 40% less likely to die after TAVI than men
2012-08-28
Munich, Germany – August 27 2012: Women with severe aortic stenosis are 40% less likely to die after transcatheter aortic valve implantation (TAVI) than men, reveals the latest data from the largest study to date of gender differences in outcomes after TAVI. The findings were presented at ESC Congress 2012 by Professor Karin Humphries from St. Paul's Hospital.
More than 1.5 million people in the US suffer from aortic stenosis, a progressive disease where the aortic valve becomes obstructed, leading to life-threatening heart problems. If left untreated, half of all patients ...
TAVI improves quality of life in patients with severe aortic stenosis for at least 1 year
2012-08-28
Munich, Germany – August 28 2012: Transcatheter aortic valve implantation (TAVI) leads to meaningful improvements in health-related quality of life in patients with severe aortic stenosis that are maintained for at least 1 year, according to a study presented at ESC Congress 2012. The results from the German transcatheter aortic valve interventions registry were presented by Professor Till Neumann, MD, from Essen, Germany.
Aortic stenosis is the most common valvular heart disease with increasing incidence especially with regard to the ageing of the population. Today, ...
Lifestyle changes could prevent 400 cardiac events and 200 deaths in Swedish PCI patients
2012-08-28
Munich, Germany – August 27 2012: Up to 400 cardiac events and 200 deaths in Swedish PCI patients could be avoided by following a heart healthy lifestyle, according to research from the SPICI study presented at ESC Congress 2012. The results were presented at ESC press conference by Professor Joep Perk from Linnaeus University and at the scientific session by Dr Roland CARLSSON.
The benefits of adherence to a heart healthy lifestyle in combination with drug treatment after an acute myocardial infarction treated with coronary artery balloon intervention (PCI) have recently ...
Smoking after stroke increases death risk by 3-fold
2012-08-28
Munich, Germany – August 28 2012: Patients who resume smoking after a stroke increase their risk of death by three-fold, according to research presented at ESC Congress 2012 by Professor Furio Colivicchi from San Filippo Neri Hospital. The researchers also found that the earlier patients resume smoking, the greater their risk of death with one year.
"It is well established that smoking increases the risk of having a stroke," said Professor Colivicchi. "Quitting smoking after an acute ischemic stroke may be more effective than any medication in reducing the risk of further ...
African research identifies strong candidate for possible single-dose malaria cure
2012-08-28
A recently discovered compound from the aminopyridine class not only has the potential to become part of a single-dose cure for all strains of malaria, but might also be able to block transmission of the parasite from person to person, according to a research collaboration involving the Medicines for Malaria Venture (MMV), based in Switzerland, and the Drug Discovery and Development Centre (H3-D) at the University of Cape Town, South Africa. On the basis of initial results it was selected by MMV for further development – making it the first compound researched on African ...
Personalized antiplatelet treatment improves outcome after PCI
2012-08-28
Munich, Germany – August 26 2012: Personalized antiplatelet treatment leads to better outcomes than standard antiplatelet treatment in patients undergoing coronary stent implantation, according to results from the MADONNA study presented at ESC Congress 2012. The findings were presented by Dr Jolanta Siller-Matula from Medical University of Vienna.
Standard antiplatelet treatment in patients undergoing percutaneous coronary intervention (PCI) consists of a dual antiplatelet therapy with aspirin and an ADP receptor inhibitor such as clopidogrel.
But measurements of platelet ...
30-day mortality after AMI drops with improved treatment
2012-08-28
Munich, Germany – August 28 2012: Improved treatment after acute myocardial infarction and less severe patient profile have reduced 30-day mortality over the past 15 years, according to research presented at ESC Congress 2012. The analysis of four French registries from 1995 to 2010 was presented by Professor Nicolas Danchin from the Hopital Européen Georges Pompidou.
Cardiologists recognize two types of myocardial infarction. The first type, ST-elevation myocardial infarction (STEMI), corresponds to the sudden, permanent occlusion of a coronary artery supplying the myocardium ...
New method: Research team analyzes stress biology in babies
2012-08-28
After waking up, the concentration of the stress hormone cortisol in saliva rises considerably; this is true not only for grown-ups but for babies as well. A research team from the Ruhr-Universität Bochum and from Basel has reported this finding in the journal Psychoneuroendocrinology. "This gives us a new, non-invasive and uncomplicated possibility to already research the activity of the stress system during infancy," Prof. Dr. Gunther Meinlschmidt, of the Clinic of Psychosomatic Medicine and Psychotherapy at the LWL University Hospital of the RUB, said. The information ...
Ten year decline in ischemic stroke after AMI
2012-08-28
Munich, Germany – August 28 2012: The risk of ischemic stroke one year after acute myocardial infarction (AMI) dropped by 21% over a ten year period, according to research presented at ESC Congress 2012. The analysis of data from two Swedish registries was presented by Dr Anders Ulvenstam, and suggests that the reduction is due to improvements in AMI care.
Ischemic stroke is a well known, relatively rare but potentially devastating complication following myocardial infarction. It can lead to severe neurological handicap and death for the patient and it is associated with ...
Global platelet reactivity identifies high risk ACS patients
2012-08-28
Munich, Germany – August 26 2012: Global platelet reactivity is more effective than responsiveness to clopidogrel in identifying acute coronary syndrome (ACS) patients at high risk of ischemic events, according to research presented at the ESC Congress today. The results from the RECLOSE 2-ACS study were presented by Dr Rossella Marcucci from Italy.
The Responsiveness to Clopidogrel and Stent thrombosis 2 – ACS (RECLOSE 2-ACS) study is a prospective, observational, referral center cohort study of 1,789 patients with acute coronary syndromes undergoing percutaneous coronary ...